We started Teiko Bio to use immune insights to help deliver life-changing therapies to those who need them most. Today, Teiko delivers on its mission by supporting therapy development and informing clinical decision-making. By using cutting-edge mass cytometry, Teiko’s leading test, the TokuProfile, maps characteristics of response, accelerates clinical pipeline candidates, and supports identification of novel discoveries.
